A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT02501161 · COMPLETED

Trial details

NCT number

NCT02501161

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-01-31

Primary completion

2018-10-03

Enrollment

1012

View on ClinicalTrials.gov